We evaluated whether neutralization of CCL22 function contributes to the inhibition of TAM-mediated cancer cell invasion and found that treatment with a CCL22 neutralizing antibody (Ab) markedly decreased the number of invaded ESCC cells in cocultures with pol-TAMs or pri-TAMs. The gene discussed is CCL22; the disease is cancer.